RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 125 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $45 | -23.7% | 41,648 | -8.5% | 0.00% | – |
| Q2 2023 | $59 | -55.0% | 45,496 | -53.9% | 0.00% | – |
| Q1 2023 | $131 | +89.9% | 98,708 | +113.0% | 0.00% | – |
| Q4 2022 | $69 | -99.2% | 46,336 | +533.3% | 0.00% | – |
| Q3 2022 | $9,000 | -10.0% | 7,317 | -15.5% | 0.00% | – |
| Q2 2022 | $10,000 | -93.1% | 8,661 | -82.2% | 0.00% | – |
| Q1 2022 | $145,000 | -87.9% | 48,528 | -89.2% | 0.00% | – |
| Q4 2021 | $1,194,000 | -8.0% | 449,970 | +26.0% | 0.00% | -100.0% |
| Q3 2021 | $1,298,000 | +26.4% | 357,244 | +51.1% | 0.00% | – |
| Q2 2021 | $1,027,000 | -29.2% | 236,452 | -44.2% | 0.00% | -100.0% |
| Q1 2021 | $1,450,000 | +169.5% | 423,923 | +175.5% | 0.00% | – |
| Q4 2020 | $538,000 | +22.0% | 153,887 | -16.5% | 0.00% | – |
| Q3 2020 | $441,000 | -3.3% | 184,299 | -26.0% | 0.00% | – |
| Q2 2020 | $456,000 | +40.3% | 248,959 | +19.4% | 0.00% | – |
| Q1 2020 | $325,000 | -38.2% | 208,455 | -15.2% | 0.00% | – |
| Q4 2019 | $526,000 | +34.2% | 245,711 | +17.3% | 0.00% | – |
| Q3 2019 | $392,000 | -11.3% | 209,495 | +23.9% | 0.00% | – |
| Q2 2019 | $442,000 | +59.0% | 169,116 | +56.4% | 0.00% | – |
| Q1 2019 | $278,000 | +18.3% | 108,111 | +5.9% | 0.00% | – |
| Q4 2018 | $235,000 | -73.1% | 102,099 | -62.4% | 0.00% | -100.0% |
| Q3 2018 | $872,000 | -55.1% | 271,555 | -60.4% | 0.00% | 0.0% |
| Q2 2018 | $1,940,000 | -41.0% | 685,105 | -26.2% | 0.00% | -66.7% |
| Q1 2018 | $3,286,000 | +89.2% | 928,670 | +107.3% | 0.00% | +200.0% |
| Q4 2017 | $1,737,000 | +258.9% | 447,991 | +135.2% | 0.00% | – |
| Q3 2017 | $484,000 | -4.5% | 190,497 | +2.7% | 0.00% | – |
| Q2 2017 | $507,000 | +378.3% | 185,469 | +478.8% | 0.00% | – |
| Q1 2017 | $106,000 | -20.3% | 32,043 | -43.0% | 0.00% | – |
| Q4 2016 | $133,000 | -25.7% | 56,207 | +14.1% | 0.00% | – |
| Q3 2016 | $179,000 | -7.3% | 49,269 | -43.1% | 0.00% | – |
| Q2 2016 | $193,000 | +101.0% | 86,651 | +80.6% | 0.00% | – |
| Q1 2016 | $96,000 | +772.7% | 47,968 | +1259.3% | 0.00% | – |
| Q4 2015 | $11,000 | +450.0% | 3,529 | +185.3% | 0.00% | – |
| Q3 2015 | $2,000 | -97.7% | 1,237 | -95.8% | 0.00% | – |
| Q2 2015 | $88,000 | +158.8% | 29,679 | +157.9% | 0.00% | – |
| Q1 2015 | $34,000 | -20.9% | 11,507 | -46.9% | 0.00% | – |
| Q4 2014 | $43,000 | -17.3% | 21,655 | -58.7% | 0.00% | – |
| Q3 2014 | $52,000 | -63.9% | 52,430 | +8.0% | 0.00% | – |
| Q2 2014 | $144,000 | -40.2% | 48,539 | -39.8% | 0.00% | – |
| Q1 2014 | $241,000 | +213.0% | 80,641 | +105.5% | 0.00% | – |
| Q4 2013 | $77,000 | -54.2% | 39,244 | -30.0% | 0.00% | – |
| Q3 2013 | $168,000 | -40.4% | 56,059 | -33.5% | 0.00% | – |
| Q2 2013 | $282,000 | – | 84,280 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 8,350,000 | $28,557,000 | 5.86% |
| Ion Asset Management Ltd. | 3,632,132 | $12,422,000 | 1.43% |
| CM Management, LLC | 500,000 | $1,710,000 | 1.27% |
| SECTOR GAMMA AS | 1,530,490 | $5,234,000 | 0.96% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $5,198,000 | 0.36% |
| Rock Springs Capital Management LP | 4,742,000 | $16,218,000 | 0.35% |
| Telemetry Investments, L.L.C. | 90,000 | $308,000 | 0.35% |
| DAFNA Capital Management LLC | 275,500 | $942,000 | 0.22% |
| KELLEHER FINANCIAL ADVISORS | 100,000 | $342,000 | 0.22% |
| Virtus ETF Advisers LLC | 91,971 | $315,000 | 0.13% |